NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,884 | -3.9% | 18,493 | -4.8% | 0.57% | -2.7% |
| Q2 2023 | $1,960 | +5.9% | 19,424 | -3.4% | 0.58% | -0.8% |
| Q1 2023 | $1,850 | +1.1% | 20,112 | -0.3% | 0.59% | -14.6% |
| Q4 2022 | $1,829 | -99.9% | 20,164 | +1.9% | 0.69% | +15.4% |
| Q3 2022 | $1,504,000 | -10.8% | 19,781 | -0.9% | 0.60% | +1.2% |
| Q2 2022 | $1,687,000 | -2.8% | 19,952 | +0.9% | 0.59% | +0.9% |
| Q1 2022 | $1,736,000 | -0.3% | 19,781 | -0.7% | 0.59% | +12.5% |
| Q4 2021 | $1,742,000 | +7.2% | 19,914 | +0.2% | 0.52% | +3.6% |
| Q3 2021 | $1,625,000 | -10.9% | 19,867 | -0.6% | 0.50% | -7.4% |
| Q2 2021 | $1,824,000 | +6.8% | 19,987 | +0.0% | 0.54% | +1.3% |
| Q1 2021 | $1,708,000 | -10.2% | 19,980 | -0.7% | 0.54% | -30.8% |
| Q4 2020 | $1,901,000 | +7.6% | 20,129 | -0.9% | 0.78% | +5.7% |
| Q3 2020 | $1,767,000 | -1.4% | 20,318 | -1.0% | 0.73% | -8.1% |
| Q2 2020 | $1,792,000 | +1.0% | 20,516 | -4.6% | 0.80% | -6.0% |
| Q1 2020 | $1,774,000 | -12.2% | 21,515 | +0.8% | 0.85% | +6.0% |
| Q4 2019 | $2,021,000 | +8.2% | 21,345 | -0.7% | 0.80% | +4.0% |
| Q3 2019 | $1,867,000 | -6.0% | 21,486 | -1.2% | 0.77% | -11.0% |
| Q2 2019 | $1,986,000 | -6.0% | 21,752 | -1.1% | 0.87% | -8.3% |
| Q1 2019 | $2,113,000 | +13.1% | 21,983 | +0.9% | 0.94% | -4.0% |
| Q4 2018 | $1,869,000 | -3.3% | 21,778 | -2.9% | 0.98% | +10.8% |
| Q3 2018 | $1,932,000 | +13.6% | 22,419 | -0.4% | 0.89% | +9.6% |
| Q2 2018 | $1,700,000 | -8.0% | 22,509 | -1.0% | 0.81% | -14.8% |
| Q1 2018 | $1,848,000 | -4.4% | 22,746 | -1.2% | 0.95% | -4.2% |
| Q4 2017 | $1,933,000 | -2.4% | 23,022 | -0.2% | 0.99% | -5.5% |
| Q3 2017 | $1,981,000 | +1.9% | 23,079 | -0.9% | 1.05% | -2.2% |
| Q2 2017 | $1,944,000 | +13.3% | 23,293 | +0.8% | 1.07% | -1.1% |
| Q1 2017 | $1,716,000 | +3.1% | 23,109 | +1.1% | 1.08% | -4.0% |
| Q4 2016 | $1,664,000 | -8.0% | 22,848 | -0.3% | 1.13% | -6.2% |
| Q3 2016 | $1,809,000 | -3.1% | 22,914 | +1.3% | 1.20% | -7.3% |
| Q2 2016 | $1,866,000 | +15.2% | 22,616 | +1.2% | 1.30% | +10.1% |
| Q1 2016 | $1,620,000 | -13.6% | 22,358 | +2.6% | 1.18% | -23.3% |
| Q4 2015 | $1,876,000 | – | 21,802 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |